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Bisphenol A (BPA) is a weak estrogenic chemi­
cal used in the production of some plastics 
and resins (in food and drink containers), 
flame retardants, dental sealants, and in the 
recycling of thermal paper (Vandenberg et al. 
2007). According to the National Health and 
Nutrition Examination Survey, the geometric 
mean urinary concentration of BPA in the gen­
eral U.S. population sampled was 2.6 µg/L in 
2003–2004; concentrations were significantly 
higher in women than in men, in children 
than in adults, and in individuals with low 
household income compared with individuals 
with higher income (Calafat et al. 2008).
BPA has been shown experimentally to inter­
act with estrogen signaling pathways through 
binding to the estrogen receptors (Naciff et al. 
2002; Vandenberg et al. 2009; Wetherill et al. 
2007) and also to act as a thyroid hormone ago­
nist (Zoeller et al. 2005). Prenatal exposure to 
BPA in mice led to alterations in brain struc­
ture and corresponding changes in behavior, 
with the latter being a notable end point for low 
dose exposure (reviewed by Chapin et al. 2008; 
Palanza et al. 2008). Alterations (elimination or 
reduction) of sexually dimorphic behaviors are 
a particularly sensitive end point for BPA expo­
sure [reviewed by National Toxicology Program 
(2008)]. However, the experimental data are 
somewhat conflicting, with a number of animal 
studies reporting effects primarily in females 
and others mainly in males. Both sexes were 
not always tested, and different test systems and 
doses were used.
There are limited data on the neuro­
developmental effects of BPA exposure in 
humans. A recent epidemiological study found 
a positive association between maternal BPA 
urinary concentrations at gestational week 16 
and externalizing behaviors, such as hyperac­
tivity and aggression, at 2 years of age, with 
the association more pronounced in girls than 
in boys (Braun et al. 2009). Within the same 
cohort, at age 3 years, the mean maternal (16 
and 26 weeks of gestation and birth) BPA 
urinary concentrations were associated with 
increased anxiety, depression, and hyperactivity 
among girls but not among boys (Braun et al. 
2011b). In contrast, in a sample of 9­year­olds, 
their mothers’ third­trimester BPA urinary 
concentrations were not associated with symp­
toms of social impairment in both sexes com­
bined, nor was there an interaction between 
prenatal BPA concentrations and child sex 
(Miodovnik et al. 2011).
In the present study we examined the asso­
ciation between prenatal adjusting for postnatal 
BPA exposure, estimated from BPA urinary 
concentrations, and behavior problems, which 
were measured by the Child Behavior Checklist 
(CBCL) (Achenbach and Rescorla 2001), in 
children 3–5 years of age. We hypothesized 
that prenatal exposure to BPA would be asso­
ciated with symptoms of behavior problems 
after taking into consideration postnatal BPA 
exposure and covariates of interest. We postu­
lated that there would be interactions between 
BPA exposure and sex of the child, as reported 
before (Braun et al. 2009, 2011b). Because 
the literature was not consistent on this point, 
we were agnostic as to the direction of effects 
within boys versus girls.
Methods
Sample selection. Participants in this study were 
mothers and their children in the Columbia 
Center for Children’s Environmental Health 
(CCCEH) New York City (NYC) cohort. 
From 1998 through 2003, pregnant African­
American and Dominican women who resided 
in Washington Heights, Harlem, or the South 
Bronx in New York City (USA) were recruited 
into a prospective cohort study (Perera et al. 
2003). Inclusion was limited to women who 
were in the age range of 18–35 years, non­
cigarette smokers, nonusers of other tobacco 
products or illicit drugs, free of diabetes, hyper­
tension, or known HIV, and who initiated 
prenatal care by the 20th week of pregnancy. 
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Background: Experimental laboratory evidence suggests that bisphenol A (BPA), an endocrine 
 disruptor, is a neurodevelopmental toxicant. However, there have been limited and inconclusive 
results with respect to sex-specific BPA effects on child behavior.
oBjective: We examined the association between prenatal BPA exposure and child behavior, 
adjusting for postnatal BPA exposure and hypothesizing sex-specific effects. 
Methods: We followed African-American and Dominican women and their children from preg-
nancy to child’s age 5 years, collecting spot urine samples from the mothers during pregnancy 
(34 weeks on average) and from children between 3 and 4 years of age to estimate BPA exposure. 
We assessed child behavior between 3 and 5 years of age using the Child Behavior Checklist 
(CBCL) and used generalized linear models to test the association between BPA exposure and child 
behavior, adjusting for potential confounders.
results: The analysis was conducted on 198 children (87 boys and 111 girls). Among boys, high 
prenatal BPA exposure (highest quartile vs. the lowest three quartiles) was associated with signifi-
cantly higher CBCL scores (more problems) on Emotionally Reactive [1.62 times greater; 95% con-
fidence interval (CI): 1.13, 2.32] and Aggressive Behavior syndromes (1.29 times greater; 95% CI: 
1.09, 1.53). Among girls, higher exposure was associated with lower scores on all syndromes, reach-
ing statistical significance for Anxious/Depressed (0.75 times as high; 95% CI: 0.57, 0.99) and 
Aggressive Behavior (0.82 times as high; 95% CI: 0.70, 0.97).
conclusion: These results suggest that prenatal exposure to BPA may affect child behavior, and 
differently among boys and girls.
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York Presbyterian Medical Center and of the 
Centers for Disease Control and Prevention 
(CDC) approved the study; mothers provided 
informed consent for their children.
Three hundred sixty­one mother–child 
pairs had prenatal BPA measurements and 
maternal prenatal questionnaire data, and 337 
children had CBCL data obtained at least once 
between the ages of 3 and 5 years (mean age, 
3.6 years). The subset included in the present 
primary analysis was composed of 198 of these 
mother–child pairs who also had available data 
on all explanatory or potential confounding 
variables of interest as well as postnatal BPA 
measurements in the child at age 3 years.
BPA measures. Spot urine samples were 
collected from the mother during pregnancy 
(range, 24–40 weeks of gestation; mean, 
34.0 weeks) and from the child between the ages 
of 3 and 4 years (range, 33–47 months; mean, 
37.1 months). Previous research has indicated 
that the intraclass correlation coefficient for BPA 
urinary concentrations from multiple samples is 
low (Braun et al. 2011a) and within­day vari­
ance for spot collections is quite high (Ye et al. 
2011). However, the ability of BPA concentra­
tions from a single spot sample to predict expo­
sure tertiles has been reported to be adequate 
(Mahalingaiah et al. 2008); and a separate study 
of minority children in NYC has shown that the 
BPA concentration in single samples is modestly 
predictive of the average 6­month concentration 
(Teitelbaum et al. 2008).
Immediately after collection, the urine 
samples were transported to the CCCEH labo­
ratory, inventoried and frozen at –80°C before 
shipment to CDC for analysis. Total (free and 
conjugated) urinary concentrations of BPA 
were measured using online solid­phase extrac­
tion coupled with high­performance liquid 
chromatography–isotope dilution–tandem 
mass spectrometry with peak focusing (Ye 
et al. 2005). The limit of detection (LOD) 
was 0.4 µg/L; concentrations below the LOD 
were given a value of LOD/2 for the statistical 
analyses. Urinary dilution was calculated from 
specific gravity (SG) measurements obtained 
using a handheld refractometer (Urine­Specific­
Gravity­Refractometer­PAL­10­S­P14643C0; 
TAGO USA, Inc., Bellevue, WA). All BPA 
concentrations were corrected for dilution by 
SG adjustment using a modification of the 
formula by Hauser et al. (2004). The formula 
BPAc = BPA × [(mean SG – 1)/(individual SG 
– 1)], where BPAc is the SG­corrected BPA 
concentration (micrograms per liter), BPA is 
the observed BPA concentration (micrograms 
per liter), and SG is the specific gravity of the 
urine sample (Hauser et al. 2004).
Behavioral outcomes. During a study visit 
when children were 3–5 years of age, research 
workers trained in neurodevelopmental test­
ing oversaw the completion of the CBCL by 
the mothers, providing guidance as needed. 
The 99­item CBCL was completed in either 
English or Spanish depending on the moth­
er’s language of choice. The CBCL consists of 
seven syndrome scales (Emotionally Reactive, 
Anxious/Depressed, Somatic Complaints, 
Withdrawn, Sleep Problems, Attention 
Problems, and Aggressive Behavior) and two 
composite scales, Internalizing Problems 
(sum of scores on Emotionally Reactive, 
Anxious/Depressed, Somatic Complaints, and 
Withdrawn) and Externalizing Problems (sum 
of scores on Attention Problems and Aggressive 
Behavior). The sum of the items of each CBCL 
syndrome scale provides a raw score denoting 
the extent of problems reported for the child 
on that scale, with higher scores correspond­
ing to more problems. The CBCL is a well­
validated measure of child behavior problems 
with good reliability and stability (Achenbach 
and Rescorla 2001).
Statistical analysis. For all analyses, both 
pre­ and postnatal BPA concentrations (SG 
adjusted) were dichotomized at the upper 
quartile (high: upper quartile vs. low: other 
three quartiles). Because the original raw scores 
of each syndrome are count data that sum the 
scores on the specific items within each scale 
and the score distribution for each syndrome 
is right­skewed, we analyzed those scores using 
a Poisson regression. The two composite scales 
are normally distributed, so we analyzed them 
as continuous variables using linear regression. 
As an alternative we also converted the raw 
scores of the seven syndrome scales to T­scores 
to compare each child with a normative sample 
of children, and dichotomized the children in 
two outcome groups for each syndrome: bor­
derline or clinical (T­score ≥ 65), or normal 
(T­score < 65) (Achenbach and Rescorla 2001). 
However, we did not analyze the dichotomous 
outcomes using logistic regression models 
because only a small percentage of children were 
classified as “borderline or clinical” according to 
this definition.
The analysis focused on BPA × sex interac­
tions because previous studies have strongly 
suggested sex differences in BPA effects on 
neurodevelopment in both rats and humans 
(Braun et al. 2009; Poimenova et al. 2010). 
Therefore, we first examined the BPA × sex 
interaction on the seven CBCL syndrome scales 
and the two composite scales using Poisson 
and linear regression, respectively, with signifi­
cant interactions defined based on interaction 
term p­values < 0.05. All parameter estimates 
and p­values were generated using SAS (version 
9.1; SAS Institute Inc., Cary, NC). Although 
our analyses involved multiple comparisons, we 
did not perform the Bonferroni adjustment to 
reduce the possibility of making a type II error 
in this observational study (Rothman 1990).
Covariates were selected for the final model 
based on whether they were known or sus­
pected risk factors according to the literature 
and our prior findings. These included sex 
of child (in models analyzing the entire set), 
gestational age of the child at birth (based on 
medical record data), mother’s intelligence score 
(measured with Test of Nonverbal Intelligence 
3rd Edition, TONI­3) (Brown et al. 1990), 
mother’s completion of high school before the 
birth of the child (yes or no), mother’s demor­
alization status during pregnancy measured 
via the Psychiatric Epidemiology Research 
Instrument–Demoralization (PERI­D) scale 
(continuous scale of 0–4) (Dohrenwend et al. 
1978), child’s age at CBCL assessment in 
months, the quality of the early home caretaking 
environment measured at 3 years of age via the 
HOME (Home Observation for Measurement 
of the Environment) Inventory (continuous 
measure) (Bradley 1994), prenatal exposure to 
environmental tobacco smoke (ETS) (any or 
none) in the home based on questionnaire, and 
postnatal BPA exposure, dichotomized at the 
upper quartile as high or low. In addition, pre­
natal phthalate exposure measured by urinary 
concentrations of phthalate metabolites dur­
ing the third trimester of pregnancy (Whyatt 
et al. 2009) was correlated with prenatal BPA 
exposure (r = 0.153, p = 0.009). Therefore, we 
adjusted for SG­adjusted mono­n­butyl phtha­
late, which had the highest correlations of all 
phthalate metabolites with prenatal BPA con­
centrations and CBCL outcomes.
Finally, we evaluated prenatal polycyclic 
aromatic hydrocarbon (PAH) exposure, mea­
sured by personal monitoring during pregnancy 
(Perera et al. 2003), and postnatal exposure 
to ETS as potential confounders in a subset 
of children with these variables. Inclusion of 
these covariates did not materially influence 
the results, in that all significant associations 
present before adjustment remained and no 
additional significant associations emerged.
Results
The sample included in this analysis consisted of 
198 children who had complete data on CBCL 
and prenatal and postnatal BPA urinary con­
centrations and covariates; there were 87 boys 
and 111 girls. Table 1 compares characteristics 
of the study subset (n = 198) with those par­
ticipants who had prenatal BPA measurements 
and maternal prenatal questionnaire data but 
who were not included because they were miss­
ing data on the CBCL or covariates (n = 159). 
Of the latter group, 24 children did not have 
a CBCL measurement completed within the 
age period of interest, 49 were missing data on 
covariates, and 86 were lacking postnatal BPA 
measurements. Demographic and exposure fac­
tors of the 198 children included in the analysis 
did not differ significantly from those of chil­
dren who were not included because of miss­
ing data, except that the percentage of mothers 
reporting prenatal ETS exposure was higher 
in the group included in the analysis (34% vs. 
Perera et al.
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23%). Furthermore, because most of the miss­
ing data were postnatal BPA measurements, we 
examined differences between the study sample 
(n = 198) and those excluded because of missing 
postnatal BPA only [n = 86; see Supplemental 
Material, Table S1 (http://dx.doi.org/10.1289/
ehp.1104492)]. The two subsets were not sig­
nificantly different in any of the variables con­
sidered except for gestational age (mean, 39.36 
weeks for the subjects included, vs. 38.87 weeks 
for the subjects excluded, p = 0.004), nor do 
they differ by CBCL score (data not shown).
The distribution of CBCL scores for children 
included in the analysis is shown in Table 2. The 
observed raw scores ranged from 0 to 42. The 
boys and girls did not differ significantly in mean 
score or percentage of children in the border­
line or clinical range. The distribution of CBCL 
scores in our study is similar to that for other 
low­income populations (Gross et al. 2006).
Table 3 shows the distribution of BPA con­
centrations by percentiles in urine samples col­
lected from mothers during pregnancy and from 
their children at 3 years of age. BPA was detect­
able in the urine of > 90% of both mothers 
and children. The ranges of total SG­adjusted 
BPA urinary concentrations in maternal and 
child urine samples were 0.24–38.53 µg/L and 
0.42–73.50 µg/L, respectively, indicating a 
wide variation in exposure. Geometric means 
for maternal and child urinary concentrations 
of BPA were 1.96 and 3.94 µg/L, respectively. 
There were no significant differences between 
boys and girls in median and mean prenatal 
or postnatal BPA concentrations, whether 
SG­adjusted or not.
Significant interactions (p < 0.05) were 
observed between prenatal BPA urinary concen­
trations (adjusting for postnatal BPA exposure 
and other covariates) and sex on Emotionally 
Reactive, Aggressive Behavior, and Internalizing 
Problems (Table 4). After stratifying on sex, the 
BPA effects were positive and significant among 
boys on Emotionally Reactive and Aggressive 
Behavior and positive and borderline signifi­
cant (p < 0.1) on Sleep Problems, Withdrawn, 
Internalizing Problems, and Externalizing 
Problems, indicating that boys with prenatal 
BPA exposure in the highest concentration 
quartile had, on average, more reported symp­
toms of problems in these areas. For the syn­
drome of Emotionally Reactive for example, 
symptoms scores were 1.62 times higher [95% 
confidence interval (CI): 1.13,2.32] among 
boys with high prenatal BPA concentrations 
compared with those with low prenatal BPA 
concentrations. In contrast, among girls, high 
BPA exposure was associated with lower scores 
for Anxious/Depressed and Aggressive Behavior 
(p < 0.05), and Internalizing Problems (p < 0.1) 
indicating that girls in the high prenatal BPA 
exposure group had, on average, fewer reported 
problems in these areas than girls in the low 
exposure group. Postnatal BPA urinary concen­
tration alone had a significant negative effect 
only on Emotionally Reactive within the entire 
sample [see Supplemental Material, Table S2 
(http://dx.doi.org/10.1289/ehp.1104492)]. 
Comparison of results before and after adjust­
ing for postnatal BPA exposure found the effect 
estimates to be similar.
In sensitivity analyses, we noticed that one 
male child had among the highest prenatal 
BPA concentrations as well as several CBCL 
scores and could be an influential variable. 
As shown in Supplemental Table S4 (http://
dx.doi.org/10.1289/ehp.1104492), removal 
of this subject from the analysis reduced the 
beta and p­values in general but did not alter 
the direction of the associations. The BPA 
× sex interactions remained significant for 
Emotionally Reactive and Aggressive Behavior 
but not for Internalizing Problems.
Discussion
In this longitudinal cohort study we examined 
the association between prenatal BPA exposure 
and child behavior in preschool­age children, 
accounting for postnatal BPA and other poten­
tial confounders. Among boys, prenatal BPA 
exposure was positively associated with higher 
scores on all syndromes and significantly associ­
ated with Emotionally Reactive and Aggressive 
Behavior. Inverse associations were seen in 
girls for all syndromes and these associations 
were significant for Anxious/Depressed and 
Aggressive Behavior.
The present finding that prenatal exposure 
to BPA is associated with more symptoms of 
certain behavioral problems in 3­ to 5­year­old 
boys is consistent with some, but not all, prior 
studies in laboratory animals. Some animal stud­
ies have shown that in male mice, prenatal BPA 
exposure is associated with increased aggression 
(Kawai et al. 2003) and with memory impair­
ment and hyperactivity (no female offspring 
were tested) (Miyagawa et al. 2007; Mizuo et al. 
2004). Others have reported changes in behav­
ior or related pathways have included greater 
anxiety­like behavior in female mice (male mice 
were not tested) (Ryan and Vandenbergh 2006), 
changes in the dopaminergic and N­methyl­
d­aspartate­ergic (NMDA) systems (associated 
with memory and behavior) (Tian et al. 2010), 
and reduction of activity and desire to explore in 
both sexes (Farabollini et al. 1999). In addition, 
mice of both sexes exposed to low doses of BPA 
prenatally (20 µg/kg of BPA daily from embry­
onic day until postnatal day 21) and through­
out lactation had an increase in serotonin and 
Table 2. Distribution of CBCL raw score outcomes in the cohort of 198 children.












n (%) in borderline 
or clinical range
Syndrome scores
Emotionally Reactive 0–11 2.08 9 (10.34) 0–9 2.08 8 (7.21)
Anxious/Depressed 0–13 3.23 10 (11.49) 0–12 3.36 11 (9.91)
Somatic Complaints 0–12 2.36 13 (14.94) 0–9 2.29 18 (16.22)
Withdrawn 0–8 1.93 11 (12.64) 0–13 2.02 16 (14.41)
Sleep Problems 0–11 2.68 3 (3.45) 0–11 3.1 7 (6.31)
Attention Problems 0–8 3.03 10 (11.49) 0–7 2.72 7 (6.31)
Aggressive Behavior 0–35 10.36 5 (5.75) 0–31 10.27 12 (10.81)
Composite scores
Internalizing Problems 0–38 9.6 11 (12.64) 0–28 9.75 10 (9.01)
Externalizing Problems 0–42 13.39 6 (6.90) 0–37 12.99 11 (9.91)
aWe converted the raw scores of the seven syndrome scales to T-scores to compare each child to a normative sample of 
children, and dichotomized the children in two outcome groups for each syndrome: borderline or clinical (T-score ≥ 65), or 
normal (T-score < 65). The Internalizing and Externalizing scales are not truncated because very few children have extremely 
low scores owing to the large number of problem items on these composite scales (Achenbach and Rescorla 2001). 
Table 1. Comparison of the characteristics of children included and excluded from BPA–CBCL analyses.
Variable
Subjects in the 
analysis (n = 198)
Subjects not 
includeda (n = 159) n p-Value
Prenatal BPA urinary concentration (μg/L) 1.96 (3.12)b 2.09 (5.20)b 159 0.089
3-year BPA urinary concentration (μg/L)  3.94 (10.93)b 4.29 (8.22)b 54 0.894
Prenatal mono-n-butyl phthalate concentration (μg/L) 63.42 ± 97.34 64.92 ± 77.56 146 0.874
Age at assessment (months) 38.27 ± 5.24 37.98 ± 6.84 142 0.673
Percent with prenatal ETS exposure 33.84 22.64 159 0.020
Percent female 56.06 49.69 159 0.230
Percent ≥ high school education 58.59 63.52 159 0.342
Percent African American 36.87 32.70 159 0.412
Gestational age at birth (weeks) 39.36 ± 1.25 39.19 ± 1.30 159 0.210
Maternal TONI score 19.83 ± 8.94 19.88 ± 7.99 131 0.958
HOME inventory 39.69 ± 6.34 39.10 ± 6.18 134 0.401
Maternal demoralization score 1.09 ± 0.63 1.12 ± 0.64 157 0.693
Values are mean ± SD or percent.
aA total of 361 children had prenatal BPA measurements and maternal prenatal questionnaire data. Some subjects were 
not included in the analysis due to missing CBCL data (n = 24), measurement of postnatal BPA (n = 86), or missing infor-
mation on at least one other covariate (n = 49). bThe means for prenatal and 3-year BPA are geometric means. 
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dopamine (involved in mood, memory, and 
learning) levels in certain brain regions com­
pared with a control group not exposed to BPA 
(Nakamura et al. 2010). In one study of rats, 
maternal BPA exposure inhibited the protein 
expression of NMDA receptor subunits and 
estrogen receptor beta of the hippocampus of 
male offspring during postnatal development, 
suggesting that BPA may affect the male devel­
oping brain; data on females were not reported 
(Xu et al. 2010). Rats prenatally exposed to BPA 
have an increase in anxiety­like behavior and 
a decrease in desire to explore, with the effects 
more pronounced in females than in males 
(Poimenova et al. 2010). BPA has also been 
found to abrogate sexual dimorphism in brain 
structure and behavior in rats (determined by 
estrogen signaling) (McCarthy 2008) and to 
disrupt cognition, social behaviors, and other 
aspects of brain function (Richter et al. 2007).
Male cynomolgus monkeys who were pre­
natally exposed to BPA behaved like non­BPA 
exposed female infants rather than non­BPA 
exposed males, suggesting that BPA affects 
behavior and sexual differentiation in male 
monkeys (Nakagami et al. 2009). Although 
interspecies variation in internal dose and 
response to BPA is a concern (Doerge et al. 
2010), BPA pharmacokinetics appear to be 
similar in women, female monkeys, and mice 
(Taylor et al. 2011).
Our findings are inconsistent with reports 
by Braun et al. (2009, 2011b). Although these 
investigators also examined sex­specific effects 
of prenatal BPA exposure on some dimen­
sions of child behavior, they reported evi­
dence of adverse effects predominantly in girls. 
Specifically, Braun et al. found a relationship 
between prenatal BPA exposure and external­
izing behavior in 2­year­old girls but not boys 
using the Behavioral Assessment System for 
Children (BASC) (Braun et al. 2009). At the 
age 3 years follow­up, they also found that ges­
tational BPA concentrations were associated 
with anxiety, depression, and hyperactivity 
among girls but not boys in their population. 
Including childhood BPA concentrations in the 
models did not significantly change the results 
(Braun et al. 2011b). They collected mater­
nal spot urine samples twice during pregnancy 
and at delivery, with urinary concentrations 
of BPA being similar to those in the present 
study (median concentrations of 1.8, 1.7, and 
1.3 µg/L at 16 and 26 weeks of pregnancy and 
at birth, respectively). Child spot urine samples 
were collected at 1, 2, and 3 years of age. The 
16­week BPA (early second trimester) prenatal 
urinary concentrations were more highly cor­
related with behavioral outcomes than were the 
prenatal 26­week (early third trimester) or birth 
BPA measurements. We note that when we 
compare the results of Braun et al. for urinary 
BPA measures at 26 weeks and at birth [i.e., 
the measurement times closest to our prenatal 
measurement (34.0 weeks on average)], both 
boys and girls had lower (i.e., better) scores on 
Internalizing and Externalizing scales, though 
the results were not statistically significant.
Although these would not fully explain the 
discrepant findings, there were a number of dif­
ferences between the study designs, especially 
the differences in the timing of sample collec­
tion. We measured BPA at a single time point in 
the third trimester of pregnancy, whereas Braun 
et al. (2011b) took three serial measurements. 
In their analysis the prenatal exposure with the 
greatest associations with child behavior at age 
2 and 3 years was measured in samples taken 
at 16 weeks, with BPA measurements taken 
later in pregnancy having weaker associations. 
In addition, the children in the CCCEH cohort 
at assessment were older (3–5 years vs. 2 and 
3 years) than in those studied by Braun et al. 
(2011b). Also, different instruments were used 
to assess child behavior, and different statistical 
models were used to analyze the data. The chil­
dren in the two study populations also differed 
by both ethnicity and socioeconomic status. 
Table 4. Association between prenatal BPA (high/low) and CBCL scores, adjusting for postnatal BPA and covariates.
All children (n = 198) Boys (n = 87) Girls (n = 111) Interaction (n = 198) 
p-ValueEstimate (95% CI) p-Value Estimate (95% CI) p-Value Estimate (95% CI) p-Value
Syndrome scores
Emotionally Reactive 1.03 (0.8, 1.32) 0.825 1.62 (1.13, 2.32) 0.008 0.74 (0.51, 1.07) 0.112 0.002
Anxious/Depressed 0.95 (0.78, 1.16) 0.627 1.23 (0.91, 1.67) 0.175 0.75 (0.57, 0.99) 0.040 0.083
Somatic Complaints 0.93 (0.74, 1.18) 0.574 1.16 (0.82, 1.64) 0.412 0.77 (0.55, 1.09) 0.139 0.123
Withdrawn 1.02 (0.8, 1.31) 0.860 1.42 (0.97, 2.07) 0.072 0.79 (0.56, 1.11) 0.177 0.068
Sleep Problems 1.08 (0.88, 1.33) 0.437 1.38 (1.00, 1.90) 0.051 0.92 (0.7, 1.21) 0.562 0.077
Attention Problems 0.98 (0.79, 1.21) 0.826 1.24 (0.90, 1.70) 0.192 0.80 (0.59, 1.08) 0.149 0.137
Aggressive Behavior 0.99 (0.88, 1.11) 0.827 1.29 (1.09, 1.53) 0.003 0.82 (0.70, 0.97) 0.017 0.001
Composite scores
Internalizing Problems –0.06 (–2.29, 2.18) 0.961 3.28 (–0.42, 6.97) 0.083 –2.35 (–5.02, 0.31) 0.084 0.037
Externalizing Problems –0.18 (–2.97, 2.6) 0.898 3.53 (–0.45, 7.5) 0.082 –2.51 (–6.31, 1.29) 0.195 0.076
Pre- and postnatal BPA concentrations were dichotomized as upper quartile based on logarithm-transformed SG-adjusted values. Four types of models were fitted separately to assess 
the main effects of prenatal BPA on both boys and girls, boys only, and girls only and the interaction effects of prenatal BPA on both boys and girls. The covariates in each model are 
the same: postnatal BPA measurements, prenatal mono-n-butyl phthalate concentration, age at assessment (in months), smoking at home (yes or no), child sex, maternal education 
(≥ high school or not), ethnicity (African American or not), gestational age (in weeks), HOME inventory score, TONI score, and PERI-D score. The seven syndromes scales were fitted 
using Poisson log-linear models. For interpretability we report the exponentiated beta in the estimate column. The two composite scales were fitted in linear models. Therefore, in that 
estimate column, the values are the original betas. In addition, the estimates for the syndrome scores indicate multiplicative difference between high and low exposure, whereas the 
estimate for composite scores indicates the average difference in scores for high versus low exposure on an absolute scale.
Table 3. Descriptive statistics of prenatal and postnatal BPA concentrationsa among 87 boys and 111 girls 
included in the analyses.
Percentile Geometric 
meanTime of BPA collection Minimum 5th 25th 50th 75th 95th Maximum Mean
Prenatal BPA
No specific gravity adjustment (μg/L)
All children < LOD 0.40 1.10 1.80 3.10 8.50 30.00 2.68 1.80
Girls < LOD < LOD 1.00 1.90 3.20 9.20 30.00 3.01 1.84
Boys < LOD 0.40 1.20 1.75 3.00 5.80 8.50 2.24 1.75
Specific gravity adjusted (μg/L)
All children 0.24 0.66 1.23 1.96 3.04 7.16 38.53 2.76 1.96
Girls 0.24 0.24 1.17 2.02 3.20 7.65 31.87 2.87 2.03
Boys 0.28 0.72 1.23 1.82 2.73 5.67 38.53 2.61 1.88
3-year BPA
No specific gravity adjustment (μg/L)
All children < LOD 0.60 1.70 3.55 6.40 27.60 90.80 6.86 3.56
Girls < LOD < LOD 1.40 3.10 8.00 31.20 62.80 6.97 3.45
Boys < LOD 0.70 2.35 3.95 6.15 19.80 90.80 6.80 3.71
Specific gravity adjusted (μg/L)
All children 0.42 1.11 2.24 3.19 7.08 20.10 73.50 6.17 3.94
Girls 0.42 0.42 2.21 3.22 7.77 20.74 42.65 6.31 4.01
Boys 0.68 1.08 2.30 3.19 6.37 14.96 73.50 6.05 3.86
aPrenatal BPA concentrations were analyzed in maternal urine samples taken during the third trimester. Postnatal BPA 
concentrations were analyzed in child urine samples taken when the child was 3 years of age.
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Specifically, our population is a low­income 
minority population, whereas most of the par­
ticipants included in the Braun study were white 
with a household income of > $40,000. Finally, 
prior research has shown that the two instru­
ments (CBCL and BASC­2) give similar, but 
not identical, results (Myers et al. 2010). Because 
the mechanisms of the association between early 
BPA exposure and child behavior are currently 
not understood, further research is needed to 
identify the factors that influence the expression 
of BPA behavioral toxicity in children.
A strength of our study is the ability to con­
trol for a number of variables based on medi­
cal record, questionnaire, biomarker, and air 
monitoring data that may affect neurobehav­
ioral development. Because we measured BPA 
concentrations in child urine, we were able to 
compare results before and after adjusting for 
postnatal BPA exposure. The finding that the 
results were similar before and after adjusting 
for postnatal exposure suggests that the prenatal 
period may be a more sensitive window for BPA 
exposure [see Supplemental Material, Tables S2, 
S3 (http://dx.doi.org/10.1289/ehp.1104492)]. 
In addition, we were able to adjust for prenatal 
phthalate exposure as a potential confounder. A 
limitation of our study is the use of a single mea­
surement of BPA in urine to categorize expo­
sure. Data are lacking on the time points during 
fetal development that are most susceptible to 
BPA. It would have been preferable to have had 
multiple BPA measures in repeated urine sam­
ples over the pregnancy and during childhood. 
Although we recognize the limitation of using 
a single spot urine sample as a measurement of 
chronic BPA exposure (Braun et al. 2011a), we 
would expect the noise in measurements to bias 
associations toward the null. Another limitation 
of this study is the relatively small sample size 
(n = 198), particularly for assessing interactions 
by sex. In addition, because our research focused 
on minority women and children living in an 
urban setting, the effects may not be generaliz­
able to other racial and ethnic groups, nor to 
other exposed populations. However, the dis­
tribution of CBCL scores in our study is similar 
to that for other low­income populations (Gross 
et al. 2006).
Additionally, because the CBCL is a parent 
account of child behavior, it is subject to limi­
tations inherent in such instruments including 
reporting bias or a difficulty inferring a child’s 
internal state. Finally, although we adjusted 
for other exposures and potential confounders, 
there is the possibility of residual confounding 
by unmeasured exposures or other stressors.
In conclusion, we report an association 
between prenatal BPA exposure and child 
behavior at age 3–5 years, with sex­specific 
associations. Among boys we found significant 
positive associations between prenatal BPA 
and CBCL scores of Emotionally Reactive and 
Aggressive Behavior. In contrast, among girls 
prenatal BPA was associated with significantly 
lower scores for the Aggressive Behavior and 
Anxious/Depressed syndromes.
Follow­up of the cohort is ongoing to fur­
ther evaluate these sex­specific associations at 
older ages. Behavioral problems such as those 
observed here may be of concern for future 
academic performance and social functioning 
(Hinshaw 1992; Wood 2006).
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